Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolution of nanomedicines for the treatment of autoimmune disease: From vehicles for drug delivery to inducers of bystander immunoregulation
Yang Yang, Pere Santamaría
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113898-113898
Open Access | Times Cited: 18

Showing 18 citing articles:

Thermosensitive Hydrogel Incorporating Prussian Blue Nanoparticles Promotes Diabetic Wound Healing via ROS Scavenging and Mitochondrial Function Restoration
Xu Zhao, Yujing Liu, Rui Ma, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 12, pp. 14059-14071
Closed Access | Times Cited: 140
Nanoparticle-Based Drug Delivery Systems for Induction of Tolerance and Treatment of Autoimmune Diseases
He Li, Yong‐Guang Yang, Tianmeng Sun
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 31
Bioresponsive Immunotherapeutic Materials
Jinpeng Han, Tao Sheng, Yuqi Zhang, et al.
Advanced Materials (2023) Vol. 36, Iss. 43
Closed Access | Times Cited: 21
Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps
Sean T. Carey, Christopher Bridgeman, Christopher M. Jewell
Advanced Science (2023) Vol. 10, Iss. 8
Open Access | Times Cited: 17
Recent advances of nanotechnology application in autoimmune diseases – A bibliometric analysis
Rendong He, Li Li, Tingjun Zhang, et al.
Nano Today (2022) Vol. 48, pp. 101694-101694
Closed Access | Times Cited: 25
Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis
Hong Ki Min, Se Hee Kim, Hae‐Rim Kim, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13913-13913
Open Access | Times Cited: 19
Lipid-Rapamycin Nanovaccines Overcome the Antidrug Antibody Barrier in Biologic Therapies
Ximu Li, Mengyao Ma, Ni An, et al.
ACS Nano (2025)
Closed Access
Revitalizando las terapias en enfermedades autoinmunes: Nanopartículas como alternativa de tratamiento
Karen Valdés Álvarez, Mauricio Rojas
Actualidades Biológicas (2025) Vol. 74, Iss. 122
Open Access
Emerging roles of mechanically activated ion channels in autoimmune disease
Zhiru Zeng, Engeng Chen, Jing Xue
Autoimmunity Reviews (2025) Vol. 24, Iss. 7, pp. 103813-103813
Closed Access
Cationic nanoparticles-based approaches for immune tolerance induction in vivo
Kuirong Mao, Jialiang Wang, Qianyue Xie, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 425-447
Closed Access | Times Cited: 3
Safety and efficacy of immune checkpoint inhibitors in advanced cancer patients with autoimmune disease: A meta-analysis
Qi Cai, Gengwei Huo, Fuyi Zhu, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 7
Open Access | Times Cited: 15
Peptide-based immunotherapy in lupus: Where are we now?
Ram P. Singh, David S. Bischoff, Satendra S Singh, et al.
Rheumatology and Immunology Research (2023) Vol. 4, Iss. 3, pp. 139-149
Open Access | Times Cited: 4
Antigen-specific nanomedicines for the treatment of autoimmune disease: target cell types, mechanisms and outcomes
Yang Yang, Pere Santamaría
Current Opinion in Biotechnology (2022) Vol. 74, pp. 285-292
Closed Access | Times Cited: 4
Safety and Efficacy of Immune Checkpoint Inhibitors in Advanced Cancer patients with Autoimmune Disease: a Meta-Analysis
Qi Cai, Gengwei Huo, Fuyi Zhu, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 2
Advanced nanoformulations for theranostics: current status and challenges
Aalok Basu, Md Saquib Hasnain, Amit Kumar Nayak, et al.
Elsevier eBooks (2023), pp. 1-19
Closed Access
Safety and Efficacy of Immune Checkpoint Inhibitors in Advanced Cancer patients with Autoimmune Disease: a Meta-Analysis
Qi Cai, Gengwei Huo, Fuyi Zhu, et al.
Research Square (Research Square) (2022)
Open Access
Safety and Efficacy of Immune Checkpoint Inhibitors in Advanced Cancer patients with Autoimmune Disease: a Meta-Analysis
Peng Chen, Qi Cai, Gengwei Huo, et al.
Research Square (Research Square) (2022)
Open Access
Editorial to “Journey into the immunological properties of engineered nanomaterials: There and back again”
Marina A. Dobrovolskaia, Kirill A. Afonin, África González‐Fernández
Advanced Drug Delivery Reviews (2021) Vol. 181, pp. 114100-114100
Closed Access
Page 1

Scroll to top